Výsledky vyhledávání - Rob van Maanen
- Zobrazuji výsledky 1 - 6 z 6
-
1
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study) Autor Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu‐Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen, Dudley Robinson
Vydáno 2017Artigo -
2
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with <i>Clostridioides (Clostridium) difficile</i> Infection: A Phase 3, Multicenter, Randomized, Sing... Autor Joshua Wolf, Krisztina Kalocsai, Clàudia Fortuny, Ştefan Lazăr, Samantha Bosis, Bartosz Korczowski, Arnaud Petit, Daniel Bradford, Rodney Croos‐Dabrera, Elodie Incera, Joost Melis, Rob van Maanen
Vydáno 2019Artigo -
3
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (S... Autor Christian Gratzke, Rob van Maanen, Christopher R. Chapple, Paul Abrams, Sender Herschorn, Dudley Robinson, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Sang Jin Yoon, С Х Аль-Шукри, Tomasz Rechberger, Elizabeth R. Mueller
Vydáno 2018Artigo -
4
Modulation of the Renin-Angiotensin System against COVID-19: A path forward? Autor Serge Camelo, Waly Dioh, J. Pedro Teixeira, Laurence W. Busse, Girish B. Nair, Gaëtan Plantefève, Capucine Morélot-Panzini, Suzana Margareth Lobo, Wesley H. Self, Sean P. Collins, Rob van Maanen, Stanislas Veillet
Vydáno 2025Revisão -
5
Challenges in developing Geroscience trials Autor Yves Rolland, Felipe Sierra, Luigi Ferrucci, Nir Barzilai, Rafael de Cabo, Joan B. Mannick, Anthony A. Oliva, William J. Evans, Davide Angioni, Philipe de Souto Barreto, Jérémy Raffin, Bruno Vellas, James L. Kirkland, Sandrine Andrieu, Daniel Bacqueville, Heike A. Bischoff‐Ferrari, Guillaume Blivet, Timothy P. Cash, Ana-Maria Cuervo, Noélie Davezac, Andrea Dimet‐Wiley, Alexander Fleming, Friedlander Gérard, Mitzi M. Gonzales, Sophie Guyonnet, Joshua M. Hare, Suzanne Hendrix, Christian Jørgensen, Matt Kaeberlein, Mehmood Khan, Stephen B. Kritchevsky, Aksana Labokha, Olivier Lairez, Stephanie Lederman, Jean Mariani, Lefkos Middleton, John C. Newman, Angelo Parini, Susan Peschin, Marco Prunotto, Sami Sagol, Suzanne M. Tomlinson, Georg C. Terstappen, Jacques Touchon, Cendrine Tourette, Rob van Maanen, Eric Verdin, Stan Watowich, Lei Zhang, Alex Zhavoronkov
Vydáno 2023Revisão -
6
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial Autor Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair, Adilson Joaquim Westheimer Cavalcante, Nara Franzin de Moraes, Estêvão Portela Nunes, Otis Barnum, Claudio Stadnik, Maria Patelli Juliani Souza Lima, Muriel Lins, Ludhmila Abrahão Hajjar, Christopher A. Lipinski, Shaheen Islam, Fabiano Ramos, Tiago Simon, Jean‐Benoît Martinot, Thomas Guimard, Arnaud Desclaux, Bertrand Lioger, Fernando Carvalho Neuenschwander, Bruno DeSouza Paolino, Alpesh Amin, Samuel Amil Acosta, Daniel F. Dilling, Edgardo Cartagena, Brian D. Snyder, Edouard Devaud, Ana Karolina Barreto Berselli Marinho, Suzana Érico Tanni, Patricia Medeiros Milhomem Beato, S. De Wit, V. Saravana Selvan, Jeffrey A. Gray, Ricardo Fernández, Valérie Pourcher, Lee Maddox, Richard Kay, Anait Azbekyan, Mounia Chabane, Cendrine Tourette, Luis Everton Esmeraldino, Pierre J. Dilda, René Lafont, Jean Mariani, Serge Camelo, Sandrine Rabut, Samuel Agus, Stanislas Veillet, Waly Dioh, Rob van Maanen, Capucine Morélot‐Panzini
Vydáno 2024Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Pathology
Adverse effect
Alternative medicine
Biology
Clinical trial
Computer science
Environmental health
Mirabegron
Overactive bladder
Placebo
Population
Randomized controlled trial
Solifenacin
Urology
Acoustics
Anesthesia
Antibiotics
Bacteria
Blood pressure
Clinical endpoint
Clostridioides
Clostridium difficile
Combination therapy
Computer network
Confidence interval
Coronavirus disease 2019 (COVID-19)
Diarrhea
Disease